Preliminary results of paclitaxel regimen and concomitant radiotherapy in advanced head and neck cancer.

被引：0
|
作者：
Duenas, MR [1 ]
Jaen, A [1 ]
Porras, I [1 ]
Sanchez-Rovira, P [1 ]
Medina, B [1 ]
Gonzalez, E [1 ]
Marios, M [1 ]
Capllonch, M [1 ]
Casanova, MA [1 ]
Lozano, A [1 ]
机构：
[1] HGE Ciudad de Jaen, Dept Med Oncol, Jaen, Spain
来源：
ANNALS OF ONCOLOGY | 2000年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
414P
引用
收藏
页码：92 / 93
页数：2
相关论文
共 50 条
  • [31] ADVANCED HEAD AND NECK-CANCER TREATED BY COMBINED RADIOTHERAPY AND VBM CYTOTOXIC REGIMEN - 4-YEAR RESULTS
    OCONNOR, AD
    CLIFFORD, P
    DALLEY, VM
    DURDENSMITH, DJ
    EDWARDS, WG
    HOLLIS, BA
    CLINICAL OTOLARYNGOLOGY, 1979, 4 (05): : 329 - 337
  • [32] Helical Tomotherapy in advanced and recurrence head and neck cancer: preliminary results
    Garibaldi, E.
    Bresciani, S.
    Salatino, A.
    Stasi, M.
    Gabriele, P.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2011, 187 (10) : 698 - 698
  • [33] Radiotherapy and concomitant weekly 3-hours infusion of paclitaxel in the treatment of head and neck cancer: Results from a phase I trial
    Panetta, A
    Palazzi, S
    Bunkheila, F
    Princivalle, S
    Venturini, A
    Ammendolia, I
    Barbieri, E
    Babini, L
    ANNALS OF ONCOLOGY, 2000, 11 : 9 - 9
  • [34] Radiotherapy and concomitant weekly 1-hour infusion of paclitaxel in the treatment of head and neck cancer - Results from a phase I trial
    Hoffmann, W
    Belka, C
    Schmidberger, H
    Budach, W
    Bochtler, H
    Hess, CF
    Bamberg, M
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1997, 38 (04): : 691 - 696
  • [35] Phase II/III randomized study of hyperfractionated radiotherapy with concomitant cetuximab versus concomitant chemotherapy in advanced nonmetastatic head and neck cancer: Preliminary report
    Al Saleh, Khalid
    Safwat, Reham
    Bedair, Ahmed
    Al Basmy, Amany
    Hooda, H. S.
    Shete, Jitendra
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [36] Concurrent paclitaxel, carboplatin and radiotherapy (CMT) with subcutaneous amifostine in advanced squamous cell head and neck cancer (SCCHN): Preliminary results of a phase II study.
    Law, A
    Kennedy, T
    Pellitteri, P
    Christie, D
    Swartzentruber, E
    Bettleyon, C
    Thomas, C
    Lewson, J
    Halupa, M
    Yumen, O
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 504S - 504S
  • [37] Induction capecitabine and cisplatin followed by hypofractionated radiotherapy in locally advanced head and neck cancer.
    Hashmi, Quratul Ain
    Mateen, Abdul
    Khan, Muhammad Saqib
    Adil, Allah Rakha
    Duraishi, Arif Moin
    Abdullah, Famya
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [38] Renal dysfunction among patients treated with radiotherapy for locoregionally advanced head and neck cancer.
    Sabari, Joshua K.
    Shifteh, Keivan
    Ow, Thomas J.
    Tassler, Andrew
    Schiff, Bradley A.
    Garg, Madhur
    Rosenstein, Maury
    Sarta, Catherine
    Haynes, Hilda
    Eng, Yoko
    Rosenblatt, Gregory
    Abramowitz, Matthew
    Schiecht, Nicolas
    Prystowsky, Michael
    Packer, Stuart H.
    Smith, Richard V.
    Haigentz, Missak
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [39] Hypofractionated palliative radiotherapy for advanced head and neck cancer: The IHF2SQ regimen
    Monnier, Laurie
    Touboul, Emmanuel
    Durdux, Catherine
    Lang, Philippe
    St Guily, Jean Lacau
    Huguet, Florence
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2013, 35 (12): : 1683 - 1688
  • [40] CONCOMITANT CHEMORADIOTHERAPY FOR ADVANCED HEAD AND NECK-CANCER
    LIN, JC
    JAN, JS
    HSU, CY
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 1994, 24 (02) : 94 - 100
12345